Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
03/16/2000 | DE19845434C1 Tissue binding peptides and related nucleotide sequences useful for tissue specific gene transfer |
03/16/2000 | CA2343136A1 Diagnostic method for detecting disturbances of the pancreas |
03/15/2000 | EP0984982A1 Lh-rh peptide analogues, their uses and pharmaceutical compositions containing them |
03/15/2000 | EP0769956B1 USE OF A GnRH ANTAGONIST FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF GONADAL-STEROID CONDITIONS |
03/15/2000 | EP0656008B1 Thrombin receptor antagonists |
03/15/2000 | EP0641358B1 BINDING PEPTIDES WHICH INTERACT WITH LIGAND GROWTH FACTORS OF THE EPIDERMAL GROWTH FACTOR RECEPTOR AND erbB-2-RECEPTOR |
03/15/2000 | EP0541726B1 Growth factor compositions, preparation and use |
03/15/2000 | CN1247543A Cyclic peptide derivatives |
03/14/2000 | US6037320 Neurotrophic factor (NT-4) |
03/14/2000 | US6037165 Methods for the preparation of human immunodeficiency virus type 2 (HIV-2) and antigens encoped thereby |
03/14/2000 | US6037137 Fluorogenic peptides for the detection of protease activity |
03/14/2000 | CA2143335C Isolated nonapeptide derived from mage-3 gene and presented by hla-a1, and uses thereof |
03/14/2000 | CA1340926C Human rhinovirus peptides |
03/09/2000 | WO2000012709A2 Phelix: a testis-specific protein expressed in cancer |
03/09/2000 | WO2000012706A1 Page-4, an x-linked gage-like gene expressed in normal and neoplastic prostate, testis and uterus, and uses therefor |
03/09/2000 | WO2000012587A2 Polyamide chains of precise length, methods to manufacture them and their conjugates |
03/09/2000 | WO2000012553A1 Cyclic prosaposin-derived peptides and uses thereof |
03/09/2000 | WO2000012540A1 Reversible boronate complexes of 1,2-cis-diol cyclic-peptides |
03/09/2000 | WO2000012538A1 Triple helix coil template having a biologically active ligand |
03/09/2000 | WO2000012524A1 Purification of oligomers using dual-end selection |
03/09/2000 | DE19845251A1 Peptide für Pharmatargeting Peptides for drug targeting |
03/09/2000 | CA2351739A1 Polyamide chains of precise length, methods to manufacture them and their conjugates with proteins |
03/09/2000 | CA2341810A1 Cyclic prosaposin-derived peptides and uses thereof |
03/09/2000 | CA2340647A1 Reversible boronate complexes of 1,2-cis-diol cyclic-peptides |
03/09/2000 | CA2340592A1 Phelix: a testis-specific protein expressed in cancer |
03/08/2000 | EP0983346A2 Short peptides which selectively modulate the activity of serine/threonine kinases |
03/08/2000 | EP0983300A1 Bpc peptide salts with organo-protective activity, the process for their preparation and their use in therapy |
03/08/2000 | EP0983297A1 New echinocandine derivatives with antimicrobial activity |
03/08/2000 | EP0835125A4 Cd4-derived peptides that inhibit immune responses |
03/07/2000 | US6034216 Low molecular weight peptidomimetic growth hormone secretagogues |
03/07/2000 | US6034066 Cysteine protease inhibitors for use in treatment of IGE mediated allergic diseases |
03/07/2000 | US6034064 Polypeptide |
03/07/2000 | US6034058 Administering polypeptide |
03/07/2000 | US6034057 Cyclic octapeptide; antiarthritic agent |
03/07/2000 | US6034056 Cyclic peptides; antiarthritic agents |
03/07/2000 | US6033884 Delivering nucleic acid into a cell. |
03/07/2000 | US6033654 Bonding together tissue with adhesive containing polyfunctional crosslinking agent and protein polymer |
03/02/2000 | WO2000011179A1 RECOMBINANT MULTIVALENT MALARIAL VACCINE AGAINST $i(PLASMODIUM FALCIPARUM) |
03/02/2000 | WO2000011032A2 Method for producing biostatin (tt-232 triacetate) and analogs thereof |
03/02/2000 | WO2000011031A1 Method for producing biostatin (tt-232 triacetate) and the analogs thereof |
03/02/2000 | WO2000011029A2 Novel anti-diabetic peptides |
03/02/2000 | WO2000011028A2 Anti-inflammatory peptides derived from il-2 and analogues thereof |
03/02/2000 | WO2000011023A2 Ring modified cyclic peptide analogs |
03/02/2000 | WO2000011022A1 Anti-cancer compounds and methods related thereto |
03/02/2000 | WO2000011020A1 Deoxyhypusine reagent and peptides |
03/02/2000 | WO2000010591A1 Peptides for inhibition of herpes simplex virus entry |
03/02/2000 | WO1999065506A3 Cancer therapy with indolicidin or cationic peptides and their polymer conjugates |
03/02/2000 | DE19941248A1 New cetrorelix analogs containing N-substituted glycine derivatives useful as LHRH antagonists, e.g. for treating hormone-dependent tumors |
03/02/2000 | CA2340676A1 Ring modified cyclic peptide analogs |
03/02/2000 | CA2306456A1 Deoxyhypusine reagent and peptides |
03/01/2000 | EP0981541A1 Psca: prostate stem cell antigen |
03/01/2000 | EP0981540A1 A NOVEL STRAIN OF $i(BACILLUS) FOR CONTROLLING PLANT DISEASES AND CORN ROOTWORM |
03/01/2000 | EP0981539A1 Dolastatin 15 derivatives with carbonyl and heterocyclic functionalities at the c-terminus |
03/01/2000 | EP0981364A1 Method and compositions for treating hyperlipidemia and other conditions |
03/01/2000 | EP0981358A1 Dolastatin-15 derivatives in combination with taxanes |
03/01/2000 | EP0618926B1 New peptide derivatives |
03/01/2000 | CN1246126A Antimicrobially active polypeptides |
03/01/2000 | CN1246125A Peptides comprising a T-cell epitope specific to collagen II |
03/01/2000 | CN1246059A Polymers |
02/29/2000 | US6031073 Cyclic polypeptides comprising a thioether linkage and methods for their preparation |
02/29/2000 | US6031072 Compounds and methods for modulating cell adhesion |
02/29/2000 | US6031071 Oligopeptide of a generic amino acid sequence having a tryptophan or phenylalanine at a specific site; capable of binding molecules or their natural receptor; for agonists or antagonists |
02/29/2000 | US6030944 Cyclohexapeptidyl bisamine compounds |
02/29/2000 | US6030835 Methods and composition for identifying group a streptococcus |
02/29/2000 | US6030640 Oligoglycine compound, fibrous microtube of oligoglycine compound and process of producing fibrous microtube |
02/29/2000 | CA1340914C Oligopeptides and their use for diagnostic and vaccination purposes for aids and arc |
02/24/2000 | WO2000009735A1 A cyclic lipopeptide from cryptosporiopsis quercina possessing antifungal activity |
02/24/2000 | WO2000009711A2 ISOLATED AND PURIFIED HUMAN SOLUBLE GUANYLYLCYCLASE α1/β1 (hsGCα1/β1) |
02/24/2000 | WO2000009558A1 Hepatitis c inhibitor peptides |
02/24/2000 | WO2000009553A2 Antimicrobial peptides isolated from the skin of american frogs |
02/24/2000 | WO2000009546A1 Process for the preparation of regular glycopeptides |
02/24/2000 | WO2000009545A1 Pentapeptide lhrh analogs |
02/24/2000 | WO2000009544A1 Heptapeptide lhrh analogs |
02/24/2000 | WO2000009537A2 Compounds having growth hormone releasing activity |
02/24/2000 | WO2000009149A1 Tnf-derived peptides for use in treating oedema |
02/24/2000 | WO2000009144A1 Methods to increase blood flow to ischemic tissue |
02/24/2000 | WO2000009143A1 Multivalent avb3 and metastasis-associated receptor ligands |
02/24/2000 | WO2000002905A3 Methods for accelerating bone and cartilage growth and repair |
02/24/2000 | WO1999064050A8 Novel potassium channel drugs and their uses |
02/24/2000 | DE19837015A1 New human soluble guanylate cyclase alpha1/beta1 and the nucleic acid encoding the subunits, useful for producing diagnostic antibodies, and for somatic gene therapy of arteriosclerosis |
02/24/2000 | CA2339330A1 Methods to increase blood flow to ischemic tissue |
02/24/2000 | CA2338885A1 Antimicrobial peptides isolated from the skin of american frogs |
02/24/2000 | CA2338283A1 Multivalent avb3 and metastasis-associated receptor ligands |
02/23/2000 | EP0980526A1 Inhibitors of nuclear protein/nuclear receptor interaction |
02/23/2000 | EP0980440A1 Fluorogenic protease substrates based on dye-dimerization |
02/23/2000 | EP0980385A1 Peptides and compounds that bind to the il-5 receptor |
02/23/2000 | EP0980240A1 Sustained-release compositions and method for preparing same |
02/23/2000 | CN1245504A Peptides and compounds that bind to receptor |
02/23/2000 | CN1049686C Diagnostics and vaccines for hepatits virus non-A and non-B |
02/22/2000 | US6028168 Lanthionine bridged peptides |
02/22/2000 | US6027711 Structurally determined metallo-constructs and applications |
02/22/2000 | CA1340911C Antiherpes cyclic peptides |
02/22/2000 | CA1340910C Fibronectin binding protein |
02/22/2000 | CA1340907C Synthetic antigen evoking anti-hiv responese |
02/17/2000 | WO2000008197A1 Method for the production of an antibiotic agent |
02/17/2000 | WO2000008049A1 Cyclic peptides with antagonistic activity specific for bradykinin b2 receptor and formulations containing them |
02/17/2000 | WO2000008046A1 Monocyclic compounds having nk-2 antagonist action and compositions containing them |
02/17/2000 | WO2000008033A1 Water soluble prodrugs of hindered alcohols or phenols |
02/17/2000 | WO2000007609A1 Peptide antagonists of zonulin and methods for use of the same |
02/17/2000 | WO1999065942A8 Cyclic somatostatin analogs |